PVD

Peripheral Venous Disease (PVD) is a vein blockage cause by a blood clot. Cath Lab Digest explores the various catheterization methods of detection and treatment of PVD. Feel free to browse through our articles below.

Angiolink's Staple-Mediated VCD Addresses Limitations of Current Technology Part II Our vascular closure devices today have significant limitations (Table 1). What we really need to do is to develop an ?ideal? vascular closure device (VCD). Thankfully, there are new technologies coming out that hopefully are addressing this issue. Figure 1 is a novel device called the Angiolink EVS? staple device. It is not yet FDA-approved, but Angiolink has just finished doing a pivotal trial and anticipate approval in the fall of 2004. We have worked on this project with Angiolink (Tauton, Massachusetts) for 4 years.

Vascular Access Site Hemostasis: "An Endovascular Surgeon's Perspective" Manual Compression May Not Be Benign Part 1 I am a classically trained cardiac and vascular surgeon and a member of the Cardiovascular Institute of the South, a group in which equal clinical and equitable partnerships have been formed between cardiologists and surgeons. This group actually encompasses approximately 45 cardiologists and 9 cardiovascular surgeons who work intimately together, so I learned long ago to respect the cath lab.

Ask the Clinical Instructor Ask the Clinical Instructor Feature: Ask the Clinical Instructor - Jason Wilson RCIS My lab is focusing more and more on peripheral vascular disease. Among the things we should learn from peripheral artery disease are the importance of assessing PVD and what it means for your patients. Check the anatomy around the pulse, note swelling, the ligament and its location, adipose, color and temperature of the leg and the pedal pulses, if the patient has one.

A Practical Approach to Endovascular Therapy fr Infrapopliteal Disease and the Treatment of Critical Leg A Practical Approach to Endovascular Therapy fr Infrapopliteal Disease and the Treatment of Critical Leg Feature: A Practical Approach to Endovascular Therapy fr Infrapopliteal Disease and the Treatment of Critical Leg - Greg Mishkel, MD and Nilesh J. Goswami, MD Interventional cardiologists have increasingly translated their coronary skills to the field of peripheral interventions. Angiography As in coronary interventions, precise imaging of the lesions prior to intervention is paramount to...

New Cardiovascular Horizons New Cardiovascular Horizons is being held November 1-4, 2006, in New Orleans.

ASOCC: The Cath Lab Digest 4th Annual Symposium on Cardiovascular Care Held June 2-4, 2005 Las Vegas Hilton, Las Vegas, Nevada Chairperson; Director, Cardiac Education & Technology Sentara Southside Hospitals, Norfolk, Virginia

Cath Lab News from the Deep South: Results of a Clinical Beta Site Study with a New Vascular Closure Device  Denise Crowe, Director of Cardiovascular Services; ? Rita Harman, Manager EAMC has three labs and one EP lab, all of which are fully equipped with diagnostic technology, including intravascular ultrasound (IVUS). 2 Vascular Closure Research Studies The cardiologists at EAMC use several devices for vascular closure, including:...

University Health System What is the size of your cath lab facility and number of staff members? University Health System (UHS) Cath Labs have 3 lab suites supported by 29 staff members, consisting of full-time and part-time clinical and non-clinical personnel. We have 14 registered nurses (RNs), 5 cardiovascular technologists (CVTs, 2 of whom carry the Registered Cardiovascular Invasive Specialist [RCIS] certification), 2 of whom carry the Registered Cardiovascular Invasive Specialist [RCIS] certification), 2 case manager RNs, 1 critical care technician, 1 administrative assistant, 1 operations manager, 1 inventory specialist, 1 data entry specialist and 1 data systems coordinator. University Hospital CCL staff range from 3 to 20-plus years of employment.

Clinical and Industry News The STENT (Strategic Transcatheter Evaluation of New Therapies) registry included follow-up on 5,566 patients at eight coronary centers in the United States who received either a Taxus stent system or a Cypher stent system, including 1,680 diabetic patients, nearly 500 of whom were insulin-treated diabetics. Despite the higher complexity of the Taxus patients, the Taxus stent system demonstrated excellent outcomes in MACE when compared to the Cypher stent system in diabetic patients overall ...

Cath Lab Digest Email Discussion Group: P.O. Meds and Conscious Sedation We have a new cardiology group at my lab, and prior to doing an intervention they want the RNs to administer P.O. medications (Plavix and aspirin) with the patient lying flat.  My first question is, do others give P.O. meds to patients after the angiogram, before moving on to intervention? (We at first refused because this was after conscious sedation.) Now my second question. This group now refuses to give sedation prior to an angiogram so that we can give the Plavix if needed. Do other labs have patients go through coronary angiograms without conscious sedation or analgesia??